Title |
Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews
|
---|---|
Published in |
Cochrane database of systematic reviews, November 2013
|
DOI | 10.1002/14651858.cd010567.pub2 |
Pubmed ID | |
Authors |
Philip J Wiffen, Sheena Derry, R Andrew Moore, Dominic Aldington, Peter Cole, Andrew SC Rice, Michael PT Lunn, Katri Hamunen, Maija Haanpaa, Eija A Kalso |
Abstract |
Antiepileptic drugs have been used for treating different types of neuropathic pain, and sometimes fibromyalgia. Our understanding of quality standards in chronic pain trials has improved to include new sources of potential bias. Individual Cochrane reviews using these new standards have assessed individual antiepileptic drugs. An early review from this group, originally published in 1998, was titled 'Anticonvulsants for acute and chronic pain'. This overview now covers the neuropathic pain aspect of that original review, which was withdrawn in 2009. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 18 | 18% |
United Kingdom | 15 | 15% |
Canada | 6 | 6% |
United States | 5 | 5% |
Australia | 4 | 4% |
Ecuador | 3 | 3% |
Venezuela, Bolivarian Republic of | 2 | 2% |
Netherlands | 2 | 2% |
Italy | 2 | 2% |
Other | 8 | 8% |
Unknown | 36 | 36% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 81 | 80% |
Practitioners (doctors, other healthcare professionals) | 13 | 13% |
Scientists | 4 | 4% |
Science communicators (journalists, bloggers, editors) | 3 | 3% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | <1% |
Spain | 3 | <1% |
Finland | 1 | <1% |
Chile | 1 | <1% |
Unknown | 473 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 75 | 16% |
Student > Bachelor | 58 | 12% |
Researcher | 52 | 11% |
Student > Doctoral Student | 36 | 7% |
Other | 35 | 7% |
Other | 100 | 21% |
Unknown | 125 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 180 | 37% |
Nursing and Health Professions | 37 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 29 | 6% |
Neuroscience | 19 | 4% |
Psychology | 14 | 3% |
Other | 60 | 12% |
Unknown | 142 | 30% |